Gerald L. Ray & Associates’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$550K Sell
11,042
-300
-3% -$14.5K 0.07% 219
2017
Q2
$543K Sell
11,342
-300
-3% -$14.3K 0.07% 216
2017
Q1
$527K Hold
11,642
0.07% 210
2016
Q4
$471K Sell
11,642
-500
-4% -$19.7K 0.07% 212
2016
Q3
$464K Sell
12,142
-1,850
-13% -$74.2K 0.07% 208
2016
Q2
$586K Sell
13,992
-500
-3% -$20.5K 0.09% 184
2016
Q1
$582K Sell
14,492
-550
-4% -$22.1K 0.09% 178
2015
Q4
$642K Sell
15,042
-485
-3% -$22.3K 0.1% 165
2015
Q3
$737K Sell
15,527
-850
-5% -$43.3K 0.12% 146
2015
Q2
$811K Sell
16,377
-150
-0.9% -$7.6K 0.12% 153
2015
Q1
$817K Sell
16,527
-50
-0.3% -$2.39K 0.12% 155
2014
Q4
$756K Buy
16,577
+6,750
+69% +$328K 0.12% 159
2014
Q3
$555K Buy
9,827
+1,500
+18% +$80.6K 0.09% 183
2014
Q2
$443K Sell
8,327
-100
-1% -$5.31K 0.08% 207
2014
Q1
$441K Hold
8,427
0.08% 199
2013
Q4
$452K Buy
8,427
+1,285
+18% +$66.3K 0.09% 188
2013
Q3
$362K Buy
7,142
+500
+8% +$25.4K 0.07% 201
2013
Q2
$342K Buy
+6,642
New +$354K 0.08% 190

Other funds holding SNY

Gerald L. Ray & Associates's SNY Position: Q3 2017 in Review

Gerald L. Ray & Associates reduced its Sanofi (SNY) stake by 2.6% in Q3 2017, selling an estimated $14.5K and leaving 11,042 shares worth $550K. The position accounts for 0.07% of the portfolio, ranked #219.

Gerald L. Ray & Associates first reported a position in SNY in Q2 2013 and has held it in 18 quarters since. The position peaked at $817K in Q1 2015. 484 funds tracked by Wall St. Rank hold SNY as of Q3 2017.

  • Gerald L. Ray & Associates held 11,042 shares of Sanofi worth $550K as of Q3 2017.
  • Gerald L. Ray & Associates sold 300 Sanofi shares in Q3 2017, an estimated $14.5K.
  • Sanofi made up 0.07% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #219 holding.
  • Gerald L. Ray & Associates first reported a position in Sanofi in Q2 2013 and has held it in 18 quarters since.
  • Gerald L. Ray & Associates's Sanofi position peaked at $817K in Q1 2015.
  • 484 funds tracked by Wall St. Rank held Sanofi as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.